Aclaris Therapeutics, Inc. (ACRS)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$4.23
-4.20%
Mkt Cap $518.56M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $2.07M | $1.29M | -37.47% | -$0.15 | -$0.16 | -6.67% | — | — |
| Q4 2025 Nov 6, 2025 | $2.07M | $3.30M | +59.29% | -$0.13 | -$0.12 | +7.69% | — | — |
| Q3 2025 Aug 7, 2025 | $1.14M | $1.78M | +56.22% | -$0.13 | -$0.13 | +0.00% | — | — |
| Q2 2025 May 8, 2025 | $3.55M | $1.46M | -59.01% | -$0.17 | -$0.12 | +29.41% | — | — |
| Q1 2025 Feb 27, 2025 | $7.04M | $9.21M | +30.82% | -$0.09 | -$0.10 | -11.11% | — | — |
| Q4 2024 Nov 6, 2024 | $2.12M | $4.35M | +105.00% | -$0.08 | -$0.11 | -37.50% | — | — |
| Q3 2024 Aug 7, 2024 | $1.82M | $2.77M | +51.98% | -$0.19 | -$0.15 | +21.05% | — | — |
| Q2 2024 May 7, 2024 | $1.37M | $2.40M | +75.04% | -$0.28 | -$0.24 | +14.29% | — | — |
| Q1 2024 Feb 27, 2024 | $3.36M | $17.57M | +422.92% | -$0.37 | -$0.30 | +18.92% | — | — |
| Q4 2023 Nov 6, 2023 | $1.57M | $9.28M | +491.21% | -$0.48 | -$0.41 | +14.58% | — | — |
| Q3 2023 Aug 7, 2023 | $1.90M | $1.87M | -1.63% | -$0.45 | -$0.42 | +6.67% | — | — |
| Q2 2023 May 8, 2023 | $1.75M | $2.53M | +44.46% | -$0.44 | -$0.42 | +4.55% | — | — |
| Q1 2023 Feb 23, 2023 | $1.99M | $7.75M | +288.82% | -$0.46 | -$0.41 | +10.87% | — | — |
| Q4 2022 Nov 8, 2022 | $1.60M | $19.02M | +1087.99% | -$0.39 | -$0.30 | +23.08% | — | — |
| Q3 2022 Aug 3, 2022 | $1.61M | $1.53M | -5.20% | -$0.36 | -$0.31 | +13.89% | — | — |
| Q2 2022 May 10, 2022 | $1.60M | $1.45M | -9.10% | -$0.39 | -$0.31 | +20.51% | — | — |
| Q1 2022 Feb 24, 2022 | $1.79M | $1.50M | -16.20% | -$0.36 | -$0.37 | -2.78% | — | — |
| Q4 2021 Nov 2, 2021 | $1.77M | $1.66M | -6.27% | -$0.27 | -$0.35 | -29.63% | — | — |
| Q3 2021 Aug 5, 2021 | $1.75M | $1.82M | +4.23% | -$0.26 | -$0.34 | -30.77% | — | — |
| Q2 2021 May 7, 2021 | $1.73M | $1.78M | +2.87% | -$0.27 | -$0.57 | -111.11% | — | — |